骨髓增生异常综合症
髓系白血病
生物
疾病
髓样
外显子组测序
外显子组
白血病
骨髓增生性疾病
慢性白血病
遗传学
基因
免疫学
医学
突变
急性白血病
病理
骨髓
作者
Haijiao Zhang,Beth Wilmot,Daniel Bottomly,Kim-Hien T. Dao,Emily A. Stevens,Christopher A. Eide,Vishesh Khanna,Angela Rofelty,Samantha L. Savage,Anna Reister Schultz,Nicola Long,Libbey White,Amy Carlos,Rachel Henson,Chenwei Lin,Robert P. Searles,Robert H. Collins,Daniel J. DeAngelo,Michael W. Deininger,Tamara Dunn
出处
期刊:Blood
[American Society of Hematology]
日期:2019-07-31
卷期号:134 (11): 867-879
被引量:81
标识
DOI:10.1182/blood.2019000611
摘要
Abstract Chronic neutrophilic leukemia (CNL), atypical chronic myeloid leukemia (aCML), and myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN-U) are a group of rare and heterogeneous myeloid disorders. There is strong morphologic resemblance among these distinct diagnostic entities as well as a lack of specific molecular markers and limited understanding of disease pathogenesis, which has made diagnosis challenging in certain cases. The treatment has remained empirical, resulting in dismal outcomes. We, therefore, performed whole-exome and RNA sequencing of these rare hematologic malignancies and present the most complete survey of the genomic landscape of these diseases to date. We observed a diversity of combinatorial mutational patterns that generally do not cluster within any one diagnosis. Gene expression analysis reveals enrichment, but not cosegregation, of clinical and genetic disease features with transcriptional clusters. In conclusion, these groups of diseases represent a continuum of related diseases rather than discrete diagnostic entities.
科研通智能强力驱动
Strongly Powered by AbleSci AI